About this trial
This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient received IV Artesunate
Patient was pregnant while receiving IV Artesunate
Patient was at least 15 years of age
Patient or legal guardian/representative gave consent for the study and to collect data from her physicians
Disqualifiers
None
Trial population
Pregnant women worldwide who were or are being treated with IV Artesunate who can be properly consented to provide personal health information on her pregnancy and agree to provide health information on her fetus, neonate, and infant child will be included in the study. Although IV Artesunate is indicated for the treatment of severe malaria, women who were treated off label for another indication who received IV Artesunate while pregnant will be included in the study as well.
Trial design
Other
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Number of pregnant females with high blood pressure
Number of pregnant females with high blood pressure reported in medical record
Number of pregnant females with severe nausea
Number of pregnant females with severe nausea reported in medical record
Number of pregnant females with vomiting
Number of pregnant females with vomiting reported in medical record
Number of pregnant females with dehydration
Number of pregnant females with dehydration reported in medical record
Sponsors and contacts
Click on the lead sponsor to view all of their trials.